Imelda Rismayani Gampur
Unknown Affiliation

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

INOVASI VAKSIN DENGUE: MENINGKATKAN PERLINDUNGAN DAN MENGATASI DEMAM BERDARAH DENGUE DI MASA DEPAN Ni Made Indriyani Kusuma Riandra; I Gede Peri Arista; Brigita olivia; Imelda Rismayani Gampur
Zona Kebidanan: Program Studi Kebidanan Universitas Batam Vol 13 No 3 (2023): AGUSTUS
Publisher : Universitas Batam

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37776/zkeb.v13i3.1211

Abstract

This study discusses Dengue Hemorrhagic Fever (DHF), a viral disease caused by the Dengue virus and can cause clinical symptoms such as fever, headache, nausea, vomiting, skin rash, and joint pain. The immunopathogenesis of DHF occurs when the Dengue virus enters the body and infects white blood cells, which can cause excessive inflammation and can lead to organ failure. The Dengue vaccine can provide protection against the Dengue virus and reduce mortality and complications of this disease. The tetravalent, monovalent, and DNA Dengue vaccines are currently being developed and their effectiveness depends on the serotype of the Dengue virus circulating in a particular area. In the future, the development of the Dengue vaccine is expected to provide more optimal protection by improving effectiveness, safety, and reducing production costs. There are several Dengue vaccine candidates being developed, including weakened virus vaccines and nanoparticle vaccines. With the development of more advanced and effective vaccines, it is hoped that the mortality and complications caused by this disease can be maximally overcome.
Trends in Neonatal Mortality as an Indicator of Basic Emergency Obstetric and Neonatal Services (PONED) Readiness in Tabanan, 2019–2023 Imelda Rismayani Gampur
Bulletin of Inspiring Developments and Achievements in Midwifery Vol. 2 No. 1 (2025): June, 2025
Publisher : CV. Get Press Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.69855/bidan.v2i1.176

Abstract

Neonatal mortality is a sensitive indicator of health system readiness in handling emergency obstetric and neonatal cases. Although Tabanan Regency reports high coverage of skilled birth attendance (>95%) and postnatal visits (KN1 and KN3 >99%), preventable neonatal deaths persist annually.This study aimed to analyze neonatal mortality trends in Tabanan Regency from 2019 to 2023 and examine their association with the readiness of Basic Emergency Obstetric and Neonatal Services (PONED). A descriptive quantitative approach using secondary data from district and provincial health profiles (2019–2023) was applied. Key indicators included neonatal mortality rate (NMR), causes of death, and service readiness components. Data were analyzed through trend visualization and determinant mapping.The NMR peaked at 9.0 per 1,000 live births in 2022 and declined to 7.2 in 2023. Leading causes included prematurity/low birth weight (28.2%), asphyxia (18.4%), and infection (14.6%). Despite service coverage being consistently high, findings indicate persistent gaps in readiness particularly in emergency referrals, skilled provider availability, and resuscitation facilities. Neonatal mortality trends in Tabanan reflect underlying limitations in emergency obstetric preparedness. Strengthening PONED readiness through clinical skill development, equipment availability, and efficient referrals is crucial to reducing neonatal deaths. NMR should be considered a proxy indicator of obstetric emergency readiness in decentralized health systems.